NEWS 

Real-time and near-time news

 

 

 

ANALYSIS

Stock analysis as news feed

 

 

VIDEO

Range of services

 

 

Newsticker

Companies
Economic News
Markets

Alnylam Pharmaceuticals Inc. Q3 Earnings Summary

|   Companies

 

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

Earnings: -$111.57 million in Q3 vs. $147.75 million in the same period last year.

EPS: -$0.87 in Q3 vs. $1.15 in the same period last year.

Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$64.20 million or -$0.50 per share for the period.

Analysts projected -$0.93 per share

Revenue: $420.146 million in Q3 vs. $313.153 million in the same period last year.

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

Alnylam Pharmaceuticals Inc. Q3 Earnings Summary

|   Companies

 

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

Earnings: -$111.57 million in Q3 vs. $147.75 million in the same period last year.

EPS: -$0.87 in Q3 vs. $1.15 in the same period last year.

Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$64.20 million or -$0.50 per share for the period.

Analysts projected -$0.93 per share

Revenue: $420.146 million in Q3 vs. $313.153 million in the same period last year.

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

Alnylam Pharmaceuticals Inc. Q3 Earnings Summary

|   Companies

 

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

Earnings: -$111.57 million in Q3 vs. $147.75 million in the same period last year.

EPS: -$0.87 in Q3 vs. $1.15 in the same period last year.

Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$64.20 million or -$0.50 per share for the period.

Analysts projected -$0.93 per share

Revenue: $420.146 million in Q3 vs. $313.153 million in the same period last year.

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

nach oben